Abstract: Electrical device including a printed circuit board, a sensor mounted on the printed circuit board and projecting from the PCB, and a sensor protection component including a housing in which is housed the sensor.

Abstract: The present disclosure relates to a method for diagnosing preeclampsia or a preeclampsia-related condition in a pregnant subject. The method is based on the measurement of the amount of the biomarker IGFBP-7 (Insulin-like Growth Factor Binding Protein 7) in a sample from the subject and on the comparison of the measured amount to a reference. Also disclosed are methods for assessing the severity of preeclampsia or a preeclampsia-related condition and methods for monitoring a preeclampsia or a preeclampsia-related condition in a pregnant subject. The present disclosure further relates to the use of the biomarker IGFBP-7 or of an agent that specifically binds to IGFBP-7 in a sample from a pregnant subject for diagnosing, for monitoring or for assessing the severity of preeclampsia or a preeclampsia-related condition. Finally, the present disclosure relates to a device or kit adapted to carry out the method of the present invention.

Abstract: The present disclosure describes a method for predicting the risk of a patient to suffer from acute kidney injury (AKI) during or after a surgical procedure or after administration of a contrast medium. The method is based on the determination of the level of the biomarker IGFBP7 (Insulin-like Growth Factor Binding Protein 7) in a body fluid sample obtained from the patient prior to the surgical procedure or prior to the administration of a contrast medium. Further, the present disclosure describes a method for predicting the risk of a patient to suffer from acute kidney injury (AKI) based on the determination of the amount of the biomarker IGFBP7 (Insulin-like Growth Factor Binding Protein 7) and Cystatin C in a body fluid sample obtained from the patient. The present disclosure further encompasses kits and devices adapted to carry out the methods of the disclosed methods.

Abstract: A housing for an inverter includes circuit elements and a cooling system, wherein the housing has four openings and the cooling system includes two channels arranged in the housing, each of which is connected to two different openings, and a condenser is arranged below the housing, wherein two openings from different channels are connected for communication by means of a connecting element arranged outside the housing and the connecting element is of rigid design and extends past the side of the condenser.

Abstract: A housing for an inverter includes circuit elements and a cooling system, wherein the housing has four openings and the cooling system includes two channels arranged in the housing, each of which is connected to two different openings, and a condenser is arranged below the housing, wherein two openings from different channels are connected for communication by means of a connecting element arranged outside the housing and the connecting element is of rigid design and extends past the side of the condenser.

Abstract: The invention relates to a system, including a bus bar device and a power converter housing, wherein the bus bar device includes a stack made of at least two bus bars and an electrically insulating insulation body, which encloses the bus bars in two insulating regions of the bus bar device, wherein each bus bar includes two opposing base surfaces extending in the direction of current flow and lateral surfaces connecting the base surfaces and extending in the direction of current flow, wherein the bus bar device includes a temperature control region formed between the insulating regions, in which the insulation body has an opening that exposes one of the lateral surfaces and a portion of at least one of the base surfaces of a respective bus bar, wherein the bus bars are thermally connected to the power converter housing in the temperature control region by a heat transfer means.

Abstract: The invention relates to a system, including a bus bar device and a power converter housing, wherein the bus bar device includes a stack made of at least two bus bars and an electrically insulating insulation body, which encloses the bus bars in two insulating regions of the bus bar device, wherein each bus bar includes two opposing base surfaces extending in the direction of current flow and lateral surfaces connecting the base surfaces and extending in the direction of current flow, wherein the bus bar device includes a temperature control region formed between the insulating regions, in which the insulation body has an opening that exposes one of the lateral surfaces and a portion of at least one of the base surfaces of a respective bus bar, wherein the bus bars are thermally connected to the power converter housing in the temperature control region by a heat transfer means.

Abstract: The present invention relates to a method of diagnosing whether a subject with no known history of atrial fibrillation is suffering from atrial fibrillation, or not, said method comprising the steps of a) determining the amount of a BNP-type peptide in a sample of said subject; b) comparing the amount the BNP-type peptide to a reference, and c) assessing intermittent ECG recordings obtained from said subject over a period of at least one week by using a handheld ECG device.

Abstract: The present disclosure relates to a method for diagnosing preeclampsia or a preeclampsia-related condition in a pregnant subject. The method is based on the measurement of the amount of the biomarker IGFBP-7 (Insulin-like Growth Factor Binding Protein 7) in a sample from the subject and on the comparison of the measured amount to a reference. Also disclosed are methods for assessing the severity of preeclampsia or a preeclampsia-related condition and methods for monitoring a preeclampsia or a preeclampsia-related condition in a pregnant subject. The present disclosure further relates to the use of the biomarker IGFBP-7 or of an agent that specifically binds to IGFBP-7 in a sample from a pregnant subject for diagnosing, for monitoring or for assessing the severity of preeclampsia or a preeclampsia-related condition. Finally, the present disclosure relates to a device or kit adapted to carry out the method of the present invention.

Abstract: The present disclosure describes a method for predicting the risk of a patient to suffer from acute kidney injury (AKI) during or after a surgical procedure or after administration of a contrast medium. The method is based on the determination of the level of the biomarker IGFBP7 (Insulin-like Growth Factor Binding Protein 7) in a body fluid sample obtained from the patient prior to the surgical procedure or prior to the administration of a contrast medium. Further, the present disclosure describes a method for predicting the risk of a patient to suffer from acute kidney injury (AKI) based on the determination of the amount of the biomarker IGFBP7 (Insulin-like Growth Factor Binding Protein 7) and Cystatin C in a body fluid sample obtained from the patient. The present disclosure further encompasses kits and devices adapted to carry out the methods of the disclosed methods.

Abstract: The present invention relates to a method of diagnosing whether a subject with no known history of atrial fibrillation is suffering from atrial fibrillation, or not, said method comprising the steps of a) determining the amount of a BNP-type peptide in a sample of said subject; b) comparing the amount the BNP-type peptide to a reference, and c) assessing intermittent ECG recordings obtained from said subject over a period of at least one week by using a handheld ECG device.